CONSULTING AGREEMENTConsulting Agreement • June 27th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances • California
AMENDMENT NO. 3 TO RIGHTS AGREEMENTRights Agreement • June 27th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances
February 8, 1999 Pacific Pharmaceuticals, Inc. 6730 Mesa Ridge Road, Suite A San Diego, CA 92121 Re: Amendment to Agreement and Plan of Merger ----------------------------------------- Dear Sirs or Madams: On December 10, 1998, Procept, Inc., a...Agreement and Plan of Merger • February 12th, 1999 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
WARRANT AGREEMENT FOR "CLASS B WARRANTS"Warrant Agreement • April 29th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances • New York
Lock-Up Agreement -----------------Lock-Up Agreement • December 15th, 1995 • Xytronyx Inc • In vitro & in vivo diagnostic substances
EXHIBIT 4.7 WARRANT AGREEMENT FOR "CLASS B WARRANTS" AGREEMENT (this "Agreement") dated as of August 9, 1996, by and between XYTRONYX, INC., a Delaware corporation (the "Company") and AMERICAN STOCK TRANSFER & TRUST COMPANY, as warrant agent (the...Warrant Agreement • June 24th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances • New York
Exhibit 4.1 SUBSCRIPTION AGREEMENT SUBSCRIPTION AGREEMENT (this "Agreement") made as of the date set forth on the signature page hereof between Xytronyx, Inc., a Delaware corporation, (the "Company") and the undersigned (the "Subscriber"). W I T N E S...Subscription Agreement • December 15th, 1995 • Xytronyx Inc • In vitro & in vivo diagnostic substances • New York
EXHIBIT 10.50 SUBSCRIPTION AGREEMENT SUBSCRIPTION AGREEMENT (this "Agreement") made as of the date set forth on the signature page hereof between Xytronyx, Inc., a Delaware corporation with its principal offices at 6555 Nancy Ridge Drive, Suite 200,...Subscription Agreement • April 29th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances • New York
AMENDMENT NO. 2 TO RIGHTS AGREEMENTRights Agreement • June 27th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances
LICENSE AGREEMENTLicense Agreement • March 23rd, 1998 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
WARRANT AGREEMENT FOR "CLASS B WARRANTS" AGREEMENT (this "Agreement") dated as of August 9, 1996, by and between XYTRONYX, INC., a Delaware corporation (the "Company") and AMERICAN STOCK TRANSFER & TRUST COMPANY, as warrant agent (the "Warrant...Warrant Agreement • November 13th, 1996 • Xytronyx Inc • In vitro & in vivo diagnostic substances • New York
EMPLOYMENT AGREEMENTEmployment Agreement • February 14th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances • New Jersey
SIDE LETTER NO. 1 TO THE PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • April 29th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances
LICENSE AGREEMENTLicense Agreement • January 12th, 1999 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
AGREEMENT AND PLAN OF MERGER BETWEEN PROCEPT, INC. PROCEPT ACQUISITION CORP. AND PACIFIC PHARMACEUTICALS, INC. _____________________________ Dated as of December 10, 1998 _____________________________Merger Agreement • February 12th, 1999 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Delaware
INTRODUCTION AGREEMENTIntroduction Agreement • January 12th, 1999 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
XYTRONYX, INC.Placement Agency Agreement • April 29th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances • New York
Exhibit 4.3 September 11, 1995 New York, New York Paramount Capital, Inc. 375 Park Avenue Suite 1501 New York, New York 10152 Dear Sirs: Xytronyx, Inc., a Delaware corporation (the "Company"), hereby confirms its agreement to retain Paramount Capital,...Placement Agent Agreement • December 15th, 1995 • Xytronyx Inc • In vitro & in vivo diagnostic substances
B-G DEVELOPMENT CORPORATION AND PACIFIC PHARMACEUTICALS, INC.Placement Agency Agreement • July 13th, 1998 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Contract Year Minimum Quantity of PTM Kits ------------- ---------------------------- 1 * 2 * 3 * 4 * 5 *Exclusive Distribution Agreement • February 13th, 1998 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
EXHIBIT 10.42 SUBSCRIPTION AGREEMENT SUBSCRIPTION AGREEMENT (this "Agreement") made as of the date set forth on the signature page hereof between B-G Development Corporation ("BGDC") Pacific Pharmaceuticals, Inc. ("Pacific" and collectively with BGDC...Subscription Agreement • July 13th, 1998 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
SUBSCRIPTION AGREEMENT (this "Agreement") made as of the date set forth on the signature page hereof between B-G Development Corporation ("BGDC") Pacific Pharmaceuticals, Inc. ("Pacific" and collectively with BGDC sometimes referred to as the "Companies"), and the undersigned (the "Subscriber").
CONSULTING AGREEMENT THIS AGREEMENT, dated as of November 14, 1997 (the "Agreement") is by and between Pacific Pharmaceuticals, Inc., a Delaware corporation having its principal office at 6730 Mesa Ridge Road, Suite A, San Diego, CA 92121 (the...Consulting Agreement • February 13th, 1998 • Pacific Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
3.3 DEFINITION OF CONTRACT YEAR. As used in this Section, the term "Contract Year" shall mean the period of twelve months commencing on the later to occur of (a) October 1, 1997, or (b) the first day of the calendar month following the Launch Date (as...Exclusive Distribution Agreement • September 29th, 1997 • Xytronyx Inc • In vitro & in vivo diagnostic substances • California
For Immediate Release: ---------------------- PROCTER & GAMBLE AND XYTRONYX SIGN AGREEMENT -------------------------------------------- ON A NEW GUM DISEASE TEST ------------------------- May Help Dental Professional Detect Gum Disease Better,...Marketing Agreement • October 11th, 1995 • Xytronyx Inc • In vitro & in vivo diagnostic substances
